These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5959473)

  • 1. A study of histamine in myeloproliferative disease.
    Gilbert HS; Warner RR; Wasserman LR
    Blood; 1966 Dec; 28(6):795-806. PubMed ID: 5959473
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the in vitro growth of peripheral leucocytes from patients with myeloproliferative disorders.
    Pegrum GD
    Br J Haematol; 1966 Nov; 12(6):689-96. PubMed ID: 5224278
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N
    Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
    Eid J; Ebert RF; Gesell MS; Spivak JL
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of myeloproliferative disorders.
    Laszlo J; Huang AT
    Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reduced glutathione (GSH) in erythrocytes in myeloproliferative diseases].
    Benöhr HC; Tigges FJ; Waller HD
    Verh Dtsch Ges Inn Med; 1973; 79():461-3. PubMed ID: 4790261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
    Cadiou M; Ruff F; Meunier F; Attalah N; Bernadou A; Zittoun R; Parrot JL; Bousser J
    Nouv Rev Fr Hematol; 1975; 15(2):261-9. PubMed ID: 126436
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary hyperuricemia in hemoblastosis].
    Richter R; Hermanny G; Hofer E; Stobbe H
    Dtsch Gesundheitsw; 1971 Nov; 26(45):2126-30. PubMed ID: 5145658
    [No Abstract]   [Full Text] [Related]  

  • 10. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF; Meuret G; Senn HJ
    Schweiz Med Wochenschr; 1974 Jan; 104(4):133-5. PubMed ID: 4521299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radioimmunometric determination of histamine in myeloproliferative syndromes].
    Bettelheim P; Valent P
    Wien Klin Wochenschr; 1989 Oct; 101(20):706-10. PubMed ID: 2480027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I; Kahn SB; Ross EM; Petkov G
    Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte histidine decarboxylase: properties and activity in myeloproliferative disorders.
    Krauss S; Gilbert HS; Wasserman LR
    Blood; 1968 Jun; 31(6):699-709. PubMed ID: 5240758
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential diagnostic criteria in chronic myeloproliferative diseases].
    Guseva SA
    Lik Sprava; 1992; (11-12):47-9. PubMed ID: 1292220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocytosis in myeloproliferative disorders.
    Corberand J; LaHarrague P; De Larrard B; Nguyen F; Pris J
    Am J Clin Pathol; 1980 Sep; 74(3):301-5. PubMed ID: 6932175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet defects in the myeloproliferative disorders.
    Inceman S; Tangün Y
    Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
    [No Abstract]   [Full Text] [Related]  

  • 20. The myeloproliferative syndromes.
    Penington DG
    Med J Aust; 1974 Jul; 2(2):56-64. PubMed ID: 4416373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.